Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Multiple sclerosis: early management

J Zajicek1

  • 1Department of Neurology, Derriford Hospital, Plymouth.

British Journal of Hospital Medicine
|February 4, 1997
PubMed
Summary
This summary is machine-generated.

New treatments for multiple sclerosis (MS) may soon influence disease course. This review examines MS pathogenesis and emerging therapies for this disabling condition.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Balance Right in Multiple Sclerosis (BRiMS): a feasibility randomised controlled trial of a falls prevention programme.

Pilot and feasibility studies·2021
Same author

Balance Right in Multiple Sclerosis (BRiMS): a guided self-management programme to reduce falls and improve quality of life, balance and mobility in people with secondary progressive multiple sclerosis: a protocol for a feasibility randomised controlled trial.

Pilot and feasibility studies·2017
Same author

Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.

BMC neurology·2016
Same author

Statistical analysis, trial design and duration in Alzheimer's disease clinical trials: a review.

International psychogeriatrics·2011
Same author

Autoimmune disease after alemtuzumab treatment for multiple sclerosis in a multicenter cohort.

Neurology·2011
Same author

Holding personal information in a disease-specific register: the perspectives of people with multiple sclerosis and professionals on consent and access.

Journal of medical ethics·2009
Same journal

The autopsy in the 1990s.

British journal of hospital medicine·1999
Same journal

Screening for breast cancer.

British journal of hospital medicine·1999
Same journal

Cost-effective monotherapy of concomitant benign prostatic hyperplasia and hypertension.

British journal of hospital medicine·1999
Same journal

Liposarcoma: a review of current diagnosis and management.

British journal of hospital medicine·1999
Same journal

How to do it in surgery: laparoscopic rectopexy.

British journal of hospital medicine·1999
Same journal

The management of ovarian cancer.

British journal of hospital medicine·1999
See all related articles

Area of Science:

  • Neurology
  • Immunology

Background:

  • Multiple sclerosis (MS) is a chronic, demyelinating disease of the central nervous system.
  • Current MS management focuses on symptom control and relapse reduction.

Purpose of the Study:

  • To review current understanding of multiple sclerosis pathogenesis.
  • To assess the potential impact of emerging therapies on MS course.

Main Methods:

  • Literature review of recent studies on MS pathogenesis.
  • Analysis of emerging therapeutic strategies for multiple sclerosis.

Main Results:

  • Advances in understanding MS pathophysiology.
  • Identification of novel therapeutic targets and agents.

Related Experiment Videos

Conclusions:

  • Emerging therapies show promise in modifying the disease course of multiple sclerosis.
  • Further research is needed to confirm the long-term efficacy and safety of these novel treatments.